Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers.

Antti Palomäkinull nullAarno PalotieJukka KoskelaKari K EklundMatti Pirinennull nullSamuli RipattiTarja LaitinenNina J Mars

Published in: Annals of the rheumatic diseases (2021)

Our findings provide estimates of lifetime risk of RA-ILD based on MUC5B mutation carrier status, demonstrating the potential of genomics for risk stratification of RA-ILD.

Keyphrases

interstitial lung disease
rheumatoid arthritis
systemic sclerosis
disease activity
idiopathic pulmonary fibrosis
ankylosing spondylitis
single cell